Loading clinical trials...
Loading clinical trials...
Phase II Study of Preoperative Chemotherapy With Ziv-aflibercept (Zaltrap) Followed by Postoperative Chemotherapy With or Without Ziv-aflibercept (Zaltrap) in Patients With Advanced Resectable Colorectal Cancer
Conditions
Interventions
Leucovorin
Oxaliplatin
+2 more
Locations
1
United States
Weill Cornell Medical College
New York, New York, United States
Start Date
February 1, 2014
Primary Completion Date
February 1, 2016
Completion Date
February 1, 2018
Last Updated
January 25, 2017
NCT04624555
NCT05080673
NCT04668872
NCT07129512
NCT04554836
NCT02232152
Lead Sponsor
Weill Medical College of Cornell University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions